News Feed
OncoDaily Pulse
OncoGrants
OncoDaily TV
NewsLetter
Voices
Not To Miss
FDA Approvals
Events By OncoDaily
New Paper Alert
OncoDaily 100
Community
OncoDaily Magazine
Career Updates
Oncology Drugs
Dialogues
Stories

Celebrities and Cancer
Immune Oncology
Breast Oncology
Gastrointestinal Oncology
Lung Oncology
Hematology
Radiotherapy
Cancer Types
Science
Trial Updates
ASCO
ESMO
ESO
MASCC
Cancer Center Near Me
Oncologist Near Me
OncoDaily Party 2025

Childhood Cancer
Health Policy
Hall of Fame
OncoIndustry
Public Health
Oncology Tech
Blog Posts
BIGR
Global Cancer Movement
History
Oncolibrary
OncoThon 2025

Services
Privacy Policy
Contact Us

Aug / 2026

August 2026
M	T	W	T	F	S	S
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30
31

« Jul

Voices
Not To Miss
FDA Approvals
Events By OncoDaily
New Paper Alert
OncoDaily 100
Community
OncoDaily Magazine
Career Updates
Oncology Drugs
Dialogues
Stories

News Feed
OncoDaily Pulse
OncoGrants
OncoDaily TV
NewsLetter

OncoDaily Newsletter

Subscribe to our newsletter

Call for Papers: “Radiation Oncology in 2026” Special Series

Call for Papers: “Radiation Oncology in 2026” Special Series

AAADV 2026: Where the Future of Cancer Drug Development Will Be Debated

AAADV 2026: Where the Future of Cancer Drug Development Will Be Debated

ESMO Clinical Practice Guideline Express Update: Daraxonrasib for Metastatic Pancreatic Cancer

ESMO Clinical Practice Guideline Express Update: Daraxonrasib for Metastatic Pancreatic Cancer

"A Movement Can Outlive Its Founders" - CancerWorld Honors Mary Buchanan's Lasting Legacy

Cancer Screening by Age: What Tests Do You Need and When?

Cancer Screening by Age: What Tests Do You Need and When?

Southern Africa Advances Health Sovereignty and Regional Health Security - Africa CDC

Southern Africa Advances Health Sovereignty and Regional Health Security - Africa CDC

HER2DX Predicts Pathologic Complete Response in HER2-Positive Breast Cancer After Neoadjuvant THP

HER2DX Predicts Pathologic Complete Response in HER2-Positive Breast Cancer After Neoadjuvant THP

RAS-Mediated Resistance Emerges Across Oncogene-Driven NSCLC

RAS-Mediated Resistance Emerges Across Oncogene-Driven NSCLC

𝐈𝐦𝐦𝐮𝐧𝐨𝐝𝐞𝐟𝐢𝐜𝐢𝐞𝐧𝐜𝐲

Mar 20, 2024 1:08 pm

Insight

St. Anna Children’s Cancer Research Institute (CCRI) is investigating how endoplasmic reticulum is linked to a newly discovered immunodeficiency

St. Anna Children’s Cancer Research Institute (CCRI) is investigating how endoplasmic reticulum is linked to a newly discovered immunodeficiency

Dec 30, 2023 4:09 am

Oncology Drugs

Spencer Knight: Here’s the current 34 approval breakdown by therapeutic area

Spencer Knight: Here’s the current 34 approval breakdown by therapeutic area

Headlines

Hesham ElGhazaly: Building Egypt’s Next Generation of Liver Cancer Research

Lung Cancer Immunotherapy: Real-World Survival and Costs in France

Françoise Meunier: Ending Financial Discrimination Against Cancer Survivors

Dame Maggie Smith and Courageus Breast Cancer Journey: Filming Harry Potter During Chemotherapy

Daffodil Day 2026: 40 Years of Hope Against Cancer

CancerWorld OncoDaily Medical Journal Hemostasis Today OncoDaily IO OncoDaily GI OncoDailyTV

OncoDaily™ | © 2023 - 2025

All rights reserved. Unauthorized reproduction, distribution, or transmission of any content on OncoDaily.com is strictly prohibited. For permission requests or inquiries, please contact OncoDaily directly. By accessing and using OncoDaily.com, you acknowledge and agree to comply with this copyright notice, as well as our Privacy Policy, Editorial Policy, Cookie Policy, and Disclaimer. Continued use of this website constitutes acceptance of all such terms and policies.

Phone number: +1 978 717 48 84

Email: info@oncodaily.com

About Privacy Policy Editorial Policy Cookie Policy Disclaimer

Crafted by Matemat

Oncology OncoDaily cancer Breast Cancer cancer care ASCO fight against cancer Lung cancer Global fight against cancer Cancer research Headlines immunotherapy ESMO NSCLC cancer treatment MD Anderson Cancer Center cancer awareness clinical trials colorectal cancer Research prostate cancer FDA Childhood Cancer UICC AACR ASCO24 chemotherapy radiation oncology Pancreatic Cancer Dana-Farber Cancer Institute American Cancer Society Robert Orlowski American Society of Clinical Oncology AI SIOP European Cancer Organisation NCI Myeloma Paper of the Day National Cancer Institute WHO Paolo Tarantino cervical cancer Precision Oncology Vivek Subbiah Myeloma radiotherapy IASLC bladder cancer multiple myeloma Memorial Sloan Kettering Cancer Center

European School of Oncology

Sitemap

Hemostasis Today

Fertility News

Oncodaily Journal

Manage Cookie Consent

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options
Manage services
Manage {vendor_count} vendors
Read more about these purposes

View preferences

{title}
{title}
{title}

Manage Cookie Consent

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options
Manage services
Manage {vendor_count} vendors
Read more about these purposes

View preferences

{title}
{title}
{title}